Clinical Trials fMRI
This page lists research, authored by NISOx and NISOx collaborators, concerned with Clinical Trials fMRI.
A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studies
Giorgos Minas, Fabio Rigat, Thomas E. Nichols, John A.D. Aston, and Nigel Stallard.
Statistics in Medicine
Validation and pilot application of [ 18F]FDG-PET in evaluation of a metabolic therapy for Alzheimer's disease
S Tzimopoulou, Vincent Cunningham, Thomas Nichols, Graham Searle, N.P. Bird, Prafull Mistry, et al.
Validation and pilot application of [ 18F]FDG-PET in evaluation of a metabolic therapy for Alzheimer's disease: 627-642.
A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease
Julian Matthews, Sofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, Graham Searle, Nick P Bird, et al.
Journal of Alzheimer's Disease
Optimizing the Design and Analysis of Clinical Functional Magnetic Resonance Imaging Research Studies
Cameron S. Carter, Stephan Heckers, Thomas Nichols, Daniel S. Pine, and Stephen Strother.
64(10): 842 - 849.
Neurodegeneration in Dementia and Depression.
Oxford Big Data Institute
University of Oxford